Section 4: Clinical Pharmacy Services

4CPS-236

MEDICATION USE DURING PREGNANCY

4CPS-226

EVALUATION OF A TARGETED MEDICATION RECONCILIATION IN PATIENTS AT THE HIGHEST RISK ADMITTED THROUGH THE EMERGENCY UNIT

4CPS-224

ANALYSIS OF INTERVENTIONS IN POLYMEDICATED ELDERLY PATIENTS

4CPS-223

EVALUATION OF ALLERGIES DURING VALIDATION OF PHARMACOLOGICAL THERAPY ACCORDING TO EAHP STATEMENTS

4CPS-221

CUTANEOUS INFECTION CAUSED BY CORYNEBACTERIUM DIPHTHERIAE: A CASE REPORT

4CPS-214

IMPLEMENTATION OF A CLINICAL PHARMACIST IN AN INTERNAL MEDICINE SERVICE OF A TERTIARY REFERRAL HOSPITAL

4CPS-211

EVALUATION OF THE INTERVENTIONS OF A CRITICAL CARE PHARMACIST IN ADDITION TO TEAM-BASED CARE IN AN INTENSIVE CARE UNIT

4CPS-203

EVALUATION OF EFFICIENCY AND CLINICAL IMPROVEMENTS OF PHARMACEUTICAL INTERVENTIONS IN A RECENTLY IMPLEMENTED SOCIAL-SANITARY CENTRE

4CPS-201

RISK OF CARDIOVASCULAR EVENTS DURING PREGNANCY: A PROSPECTIVE OBSERVATIONAL STUDY

4CPS-199

INTRODUCING A CLINICAL PHARMACIST TO A CARE OF THE ELDERLY (COE) DAY HOSPITAL

4CPS-180

APPLYING DIFFERENT SCALES FOR CALCULATING THE ANTICHOLINERGIC BURDEN IN OLDER PATIENTS

4CPS-177

ANTICHOLINERGIC RISK IN ELDERLY PATIENTS WITH DEMENTIA TAKING CHOLINESTERASE INHIBITORS

4CPS-150

USE OF ADALIMUMAB FOR HIDRADENITIS SUPPURATIVA

4CPS-143

TOPICAL APPLICATION OF RAPAMYCIN 0.4% FOR TREATMENT OF FACIAL ANGIOKERATOMAS IN A PAEDIATRIC PATIENT

4CPS-142

ANALYSIS OF PRESCRIBING AND CLINICAL OUTCOMES OF VEDOLIZUMAB TREATMENT IN A UNIVERSITY CARE HOSPITAL

Pages